Janux Therapeutics Inc header image

Janux Therapeutics Inc

JANX

Equity

ISIN null / Valor 111742522

NASDAQ (2026-09-08)

USD 20.04-0.99%

Janux Therapeutics Inc
UMushroom community rating:

3.47 45 votes No rating yet

NegativeNeutralPositive

About company

Janux Therapeutics Inc., founded in 2017, is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. The company leverages its proprietary technology to create next-generation T cell engagers designed to target and eliminate cancer cells while minimizing damage to healthy tissues. Janux successfully completed its initial public offering (IPO) in June 2021 and advanced its first therapeutic program to clinical trials in the latter half of 2022. The company's approach emphasizes a collaborative and data-driven culture to foster scientific innovation and accelerate the development of its therapeutic pipeline.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-19.2%1Y

96.8%3Y

-24.8%5Y

Performance

91.3%1Y

107%3Y

98.2%5Y

Volatility

1225 M

Market cap (USD)

1,061,774

Daily traded volume (Shares)

53.71 / 52.27

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.47

45 votes

Performance:

3.53

Innovation:

3.68

Society:

3.53

Nature:

3.29

Aiman Harith Muhaimin Agos Sawal

UK, 18 May 2026

Hard fall

Jakub Wrona

Switzerland, 23 Mar 2026

Goof

Thomas Chamier

UK, 03 Mar 2026

Way too Volatile

EQUITIES OF THE SAME SECTOR

Draegerwerk AG & Co. KGaA

Draegerwerk AG & Co. KGaA Valor: 330445

Annual Return

-50%0%+50%

Risk level

110

0.48%EUR 83.20

Global Health Limited

Global Health Limited Valor: 122795249

Annual Return

-50%0%+50%

Risk level

110

0.38%INR 1,427.35

Mankind Pharma Ltd.

Mankind Pharma Ltd. Valor: 126566338

Annual Return

-50%0%+50%

Risk level

110

-0.70%INR 2,305.85

Concord Biotech Ltd.

Concord Biotech Ltd. Valor: 128746036

Annual Return

-50%0%+50%

Risk level

110

1.89%INR 1,469.70

Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited Valor: 11650098

Annual Return

-50%0%+50%

Risk level

110

0.46%INR 8,800.00

aap Implantate AG

aap Implantate AG Valor: 57872565

Annual Return

-50%0%+50%

Risk level

110

0.00%EUR 1.75

Alcon Inc.

Alcon Inc. Valor: 43249246

Annual Return

-50%0%+50%

Risk level

110

-2.00%CHF 55.82

Straumann Holding Ltd

Straumann Holding Ltd Valor: 117544866

Annual Return

-50%0%+50%

Risk level

110

0.60%CHF 93.58

BACHEM HOLDING LTD

BACHEM HOLDING LTD Valor: 117649372

Annual Return

-50%0%+50%

Risk level

110

2.14%CHF 78.60

Tecan Group Ltd.

Tecan Group Ltd. Valor: 1210019

Annual Return

-50%0%+50%

Risk level

110

0.41%CHF 197.80

SIX

FactSet

Clearbit

Logos provided by Clearbit